A Pharmacodynamic Explanation for the Rapid Onset/Offset of Rapacuronium Bromide
- 1 January 1999
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 90 (1) , 16-23
- https://doi.org/10.1097/00000542-199901000-00005
Abstract
Background: Nondepolarizing muscle relaxants differ in their time course at the laryngeal adductors and the adductor pollicis, a result of differences in equilibration delays between plasma and effect sites, the sensitivity of each muscle to the relaxant, and the steepness of the concentration-effect relation at each muscle (the Hill factor). To determine whether similar differences exist for rapacuronium, a muscle relaxant with rapid onset and offset, the authors determined its pharmacodynamic characteristics. Methods: The twitch tensions of the adductor pollicis and the laryngeal adductors (via a tracheal tube cuff positioned at the vocal cords) were measured in 10 volunteers who were anesthetized with propofoL Rapacuronium, 1.5 mg/kg, was given and blood samples were collected. A semiparametric effect compartment pharmacodynamic model was fit to values for rapacuronium plasma concentrations and twitch tension of the adductor pollicis and laryngeal adductors. Results: Equilibration between the rapacuronium plasma concentration and both effect sites was rapid (typical values for the rate constant for equilibration between plasma and the effect site are 0.405 per min for the adductor pollicis and 0.630 per min for the laryngeal adductors) and was more rapid at the laryngeal adductors than at the adductor pollicis (ratio, 1.59+/-0.16; mean +/- SD). The steady state rapacuronium plasma concentration that depressed twitch tension by 50% and the Hill factor were similar for the two muscles. Conclusions: The rapid onset and offset of rapacuronium can be explained by the rapid equilibration between concentrations in plasma and at the effect site. Unlike the finding for other nondepolarizing muscle relaxants, the laryngeal muscles are not resistant to rapacuronium.Keywords
This publication has 20 references indexed in Scilit:
- Dose-Ranging Study in Younger Adult and Elderly Patients of ORG 9487, a New, Rapid-Onset, Short-Duration Muscle RelaxantAnesthesia & Analgesia, 1997
- The Phamtacokinetics and Pharmacodynamics of the Stereoisomers of Mivacurium in Patients Receiving Nitrous Oxide/Opioid/Barbiturate AnesthesiaAnesthesiology, 1994
- The Orbicularis Oculi and the Adductor Pollicis Muscles as Monitors of Atracuriurn Block of Laryngeal MusclesAnesthesia & Analgesia, 1993
- Importance of Early Blood Sampling on Vecuronium Pharmacokinetic and Pharmacodynamic ParametersClinical Pharmacokinetics, 1993
- Pharmacokinetics of Rocuronium Bromide (ORG 9426) in Patients with Normal Renal Function or Patients Undergoing Cadaver Renal TransplantationAnesthesiology, 1992
- Vecuronium Neuromuscular Blockade at the Adductor Muscles of the Larynx and Adductor PollicisAnesthesiology, 1991
- A Method to Measure Elicited Contraction of Laryngeal Adductor Muscles during AnesthesiaAnesthesiology, 1991
- Vecuronium Neuromuscular Blockade at the Diaphragm, the Orbicularis Oculi, and Adductor Pollicis MusclesAnesthesiology, 1990
- The Relationship Between Adductor Pollicis Twitch Tension and Core, Skin, and Muscle Temperature during Nitrous Oxide—Isoflurane Anesthesia in HumansAnesthesiology, 1989
- Pancuronium, Gallamine, and d-Tubocurarine ComparedAnesthesiology, 1989